{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:33:49Z","timestamp":1794051229548,"version":"4.8.0"},"reference-count":84,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:sec><jats:title>CONTEXT:<\/jats:title><jats:p>Children with incurable cancer may participate in research studies at the end of life (EOL). These studies create knowledge that can improve the care of future patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To describe stakeholder perspectives regarding research studies involving children with cancer at the EOL by conduct of a systematic review.<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA SOURCES:<\/jats:title><jats:p>We used the following data sources: Ovid Medline, Embase, the Cumulative Index to Nursing and Allied Health Literature, PsycINFO, Web of Science, and ProQuest (inception until August 2020).<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY SELECTION:<\/jats:title><jats:p>We selected 24 articles published in English that examined perceptions or experiences of research participation for children with cancer at the EOL from the perspectives of children, parents, and health professionals (HPs).<\/jats:p><\/jats:sec><jats:sec><jats:title>DATA EXTRACTION:<\/jats:title><jats:p>Two authors independently extracted data, assessed study quality, and performed thematic analysis and synthesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Eight themes were identified: (1) seeking control; (2) faith, hope, and uncertainty; (3) being a good parent; (4) helping others; (5) barriers and facilitators; (6) information and understanding; (7) the role of HPs in consent and beyond; and (8) involvement of the child in decision-making.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS:<\/jats:title><jats:p>Study designs were heterogeneous. Only one study discussed palliative care research.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Some families participate in EOL research seeking to gain control and sustain hope, despite uncertainty. Other families choose against research, prioritizing quality of life. Parents may perceive research participation as the role of a \u201cgood parent\u201d and hope to help others. HPs have positive views of EOL research but fear that parents lack understanding of the purpose of studies and the likelihood of benefit. We identified barriers to research participation and informed consent.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2020-003780","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T09:29:05Z","timestamp":1613554145000},"source":"Crossref","is-referenced-by-count":7,"title":["End-of-Life Childhood Cancer Research: A Systematic Review"],"prefix":"10.1542","volume":"147","author":[{"given":"Fyeza","family":"Hasan","sequence":"first","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Widger","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Canada;"},{"name":"Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Sung","sequence":"additional","affiliation":[{"name":"The Hospital for Sick Children, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wheaton","sequence":"additional","affiliation":[{"name":"Kingston Health Sciences Centre, Kingston, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"2021120906282167300_B1","volume-title":"Cancer Facts & Figures 2019","author":"American Cancer Society","year":"2019"},{"issue":"1","key":"2021120906282167300_B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40272-014-0113-1","article-title":"The complexity of consenting to clinical research in phase I pediatric cancer studies","volume":"17","author":"Schechter","year":"2015","journal-title":"Paediatr Drugs"},{"issue":"33","key":"2021120906282167300_B3","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1200\/JCO.2005.02.1568","article-title":"Pediatric phase I trials in oncology: an analysis of study conduct efficiency","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"2021120906282167300_B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3563638","article-title":"The ethics of phase I pediatric oncology trials","volume":"17","author":"Ackerman","year":"1995","journal-title":"IRB"},{"issue":"3","key":"2021120906282167300_B5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.2014.58.2635","article-title":"American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment","volume":"33","author":"Weber","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"2021120906282167300_B6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00002820-200104000-00007","article-title":"End-of-life decision making by adolescents, parents, and healthcare providers in pediatric oncology: research to evidence-based practice guidelines","volume":"24","author":"Hinds","year":"2001","journal-title":"Cancer Nurs"},{"issue":"36","key":"2021120906282167300_B7","doi-asserted-by":"crossref","first-page":"9146","DOI":"10.1200\/JCO.2005.10.538","article-title":"End-of-life care preferences of pediatric patients with cancer","volume":"23","author":"Hinds","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021120906282167300_B8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1542\/peds.2005-1479","article-title":"Symptoms affecting children with malignancies during the last month of life: a nationwide follow-up","volume":"117","author":"Jalmsell","year":"2006","journal-title":"Pediatrics"},{"key":"2021120906282167300_B9","volume-title":"Improving Palliative Care for Cancer","author":"Hilden","year":"2001"},{"issue":"2","key":"2021120906282167300_B10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2012.238","article-title":"Palliative care for children with cancer","volume":"10","author":"Waldman","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2021120906282167300_B11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/pbc.24450","article-title":"Decision making in pediatric oncology: evaluation and incorporation of patient and parent preferences","volume":"60","author":"Sung","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2021120906282167300_B12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.12968\/ijpn.2000.6.7.9070","article-title":"Paediatric palliative care: a lack of research-based evidence","volume":"6","author":"Cooley","year":"2000","journal-title":"Int J Palliat Nurs"},{"issue":"4","key":"2021120906282167300_B13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/082585970802400402","article-title":"Research priorities in pediatric palliative care: a Delphi study","volume":"24","author":"Steele","year":"2008","journal-title":"J Palliat Care"},{"issue":"6","key":"2021120906282167300_B14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jpainsymman.2014.12.010","article-title":"Feasibility of conducting a palliative care randomized controlled trial in children with advanced cancer: assessment of the PediQUEST study","volume":"49","author":"Dussel","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2021120906282167300_B15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1043454204264386","article-title":"End-of-life research as a priority for pediatric oncology","volume":"21","author":"Hinds","year":"2004","journal-title":"J Pediatr Oncol Nurs"},{"issue":"19","key":"2021120906282167300_B16","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1200\/JCO.2005.04.9296","article-title":"Rethinking risk-benefit assessment for phase I cancer trials","volume":"24","author":"Joffe","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"2021120906282167300_B17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/08989620300502","article-title":"Pediatric ethics and early-phase childhood cancer research: conflicted goals and the prospect of benefit","volume":"10","author":"Kodish","year":"2003","journal-title":"Account Res"},{"issue":"11","key":"2021120906282167300_B18","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.1992.10.11.1810","article-title":"Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons","volume":"10","author":"Kodish","year":"1992","journal-title":"J Clin Oncol"},{"issue":"3\u20134","key":"2021120906282167300_B19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0160-2527(82)90026-7","article-title":"The therapeutic misconception: informed consent in psychiatric research","volume":"5","author":"Appelbaum","year":"1982","journal-title":"Int J Law Psychiatry"},{"issue":"1","key":"2021120906282167300_B20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2307\/3564408","article-title":"Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism","volume":"25","author":"Horng","year":"2003","journal-title":"IRB"},{"issue":"5","key":"2021120906282167300_B21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jme.2005.015685","article-title":"Phase I oncology trials: why the therapeutic misconception will not go away","volume":"32","author":"Glannon","year":"2006","journal-title":"J Med Ethics"},{"key":"2021120906282167300_B22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2431-14-124","article-title":"When to stop? Decision-making when children\u2019s cancer treatment is no longer curative: a mixed-method systematic review","volume":"14","author":"Valdez-Martinez","year":"2014","journal-title":"BMC Pediatr"},{"issue":"6","key":"2021120906282167300_B23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/1043454212456905","article-title":"Parental decision making for children with cancer at the end of life: a meta-ethnography","volume":"29","author":"Heinze","year":"2012","journal-title":"J Pediatr Oncol Nurs"},{"key":"2021120906282167300_B24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"7","key":"2021120906282167300_B25","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"6","key":"2021120906282167300_B26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"7451","key":"2021120906282167300_B27","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.328.7451.1312","article-title":"Selecting, designing, and developing your questionnaire","volume":"328","author":"Boynton","year":"2004","journal-title":"BMJ"},{"issue":"10","key":"2021120906282167300_B28","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2021120906282167300_B29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2021120906282167300_B30","doi-asserted-by":"crossref","first-page":"e26916","DOI":"10.1002\/pbc.26916","article-title":"Enrollment in early-phase clinical trials in pediatric oncology: the experience at Institut Curie","volume":"65","author":"Surun","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2021120906282167300_B31","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1002\/pbc.24522","article-title":"Physician perceptions and beliefs of phase I trials in pediatric oncology","volume":"60","author":"Gilliam","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2021120906282167300_B32","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1097\/NCC.0000000000000099","article-title":"Physician and nurse beliefs of phase 1 trials in pediatric oncology","volume":"37","author":"Barnes","year":"2014","journal-title":"Cancer Nurs"},{"issue":"5","key":"2021120906282167300_B33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jpc.14248","article-title":"Enrolment in paediatric oncology early-phase clinical trials: the health-care professionals\u2019 perspective","volume":"55","author":"Robertson","year":"2019","journal-title":"J Paediatr Child Health"},{"issue":"13","key":"2021120906282167300_B34","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/cncr.25158","article-title":"Informed consent for pediatric phase 1 cancer trials: physicians\u2019 perspectives","volume":"116","author":"Yap","year":"2010","journal-title":"Cancer"},{"issue":"5","key":"2021120906282167300_B35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/pbc.24326","article-title":"Adolescent perspectives on phase I cancer research","volume":"60","author":"Miller","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2021120906282167300_B36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/104345420201900402","article-title":"Parents\u2019 views of their children\u2019s participation in phase I oncology clinical trials","volume":"19","author":"Deatrick","year":"2002","journal-title":"J Pediatr Oncol Nurs"},{"issue":"20","key":"2021120906282167300_B37","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1200\/JCO.2009.26.6502","article-title":"Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate\/terminal care option","volume":"28","author":"Maurer","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"2021120906282167300_B38","first-page":"1523","article-title":"Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer","volume":"24","author":"Hinds","year":"1997","journal-title":"Oncol Nurs Forum"},{"issue":"10","key":"2021120906282167300_B39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/archdischild-2018-315237","article-title":"Parents\u2019 and children\u2019s comprehension and decision in a paediatric early phase oncology trial: a prospective study","volume":"104","author":"B\u00e9ranger","year":"2019","journal-title":"Arch Dis Child"},{"issue":"5","key":"2021120906282167300_B40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/1049732318766513","article-title":"Parental experiences of child participation in a phase I pediatric oncology clinical trial: \u201cwe don\u2019t have time to waste\u201d","volume":"29","author":"Crane","year":"2019","journal-title":"Qual Health Res"},{"issue":"9","key":"2021120906282167300_B41","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1200\/JCO.2000.18.9.1900","article-title":"Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children\u2019s Cancer Study Group and the Pediatric Oncology Group","volume":"18","author":"Estlin","year":"2000","journal-title":"J Clin Oncol"},{"issue":"14","key":"2021120906282167300_B42","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/cncr.29354","article-title":"Practical communication guidance to improve phase 1 informed consent conversations and decision-making in pediatric oncology","volume":"121","author":"Johnson","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"2021120906282167300_B43","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/apa.13405","article-title":"Participation in a clinical trial for a child with cancer is burdensome for a minority of children","volume":"105","author":"van der Geest","year":"2016","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021120906282167300_B44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1043454207311742","article-title":"An exploratory survey of nurses\u2019 perceptions of phase I clinical trials in pediatric oncology","volume":"25","author":"Chang","year":"2008","journal-title":"J Pediatr Oncol Nurs"},{"issue":"3","key":"2021120906282167300_B45","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0022-3476(82)80092-9","article-title":"Therapeutic choices made by patients with end-stage cancer","volume":"101","author":"Nitschke","year":"1982","journal-title":"J Pediatr"},{"issue":"2","key":"2021120906282167300_B46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jpepsy\/2.2.58","article-title":"The final-stage conference: the patient\u2019s decision on research drugs in pediatric oncology","volume":"2","author":"Nitschke","year":"1977","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"2021120906282167300_B47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S1478951505050315","article-title":"Health-related quality of life and enrollment in phase 1 trials in children with incurable cancer","volume":"3","author":"Barrera","year":"2005","journal-title":"Palliat Support Care"},{"issue":"2","key":"2021120906282167300_B48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08880018709141257","article-title":"Experimental chemotherapy in children with cancer\u2013a parent\u2019s view","volume":"4","author":"Kamps","year":"1987","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"2021120906282167300_B49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/apa.15010","article-title":"Balancing values and obligations when obtaining informed consent: healthcare professionals\u2019 experiences in Swedish paediatric oncology","volume":"109","author":"Schr\u00f6der H\u00e5kansson","year":"2020","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021120906282167300_B50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pbc.22529","article-title":"Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children\u2019s Oncology Group phase 1 consortium study","volume":"55","author":"Berg","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"29","key":"2021120906282167300_B52","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1200\/JCO.2007.15.6059","article-title":"Parents\u2019 views of cancer-directed therapy for children with no realistic chance for cure","volume":"26","author":"Mack","year":"2008","journal-title":"J Clin Oncol"},{"issue":"23","key":"2021120906282167300_B51","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1002\/cncr.28335","article-title":"Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials","volume":"119","author":"Baker","year":"2013","journal-title":"Cancer"},{"issue":"17","key":"2021120906282167300_B53","doi-asserted-by":"crossref","first-page":"E1252","DOI":"10.1503\/cmaj.110392","article-title":"Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals","volume":"183","author":"Tomlinson","year":"2011","journal-title":"CMAJ"},{"issue":"14","key":"2021120906282167300_B54","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.ejca.2011.04.038","article-title":"Factors affecting treatment choices in paediatric palliative care: comparing parents and health professionals","volume":"47","author":"Tomlinson","year":"2011","journal-title":"Eur J Cancer"},{"issue":"5","key":"2021120906282167300_B55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1043454209360839","article-title":"How do I cope? Factors affecting mothers\u2019 abilities to cope with pediatric cancer","volume":"27","author":"Fletcher","year":"2010","journal-title":"J Pediatr Oncol Nurs"},{"issue":"2","key":"2021120906282167300_B56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1741-3729.2002.00103.x","article-title":"Family resiliency in childhood cancer","volume":"51","author":"McCubbin","year":"2002","journal-title":"Fam Relat"},{"issue":"9","key":"2021120906282167300_B57","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0277-9536(03)00338-1","article-title":"Therapeutic misconception and the appreciation of risks in clinical trials","volume":"58","author":"Lidz","year":"2004","journal-title":"Soc Sci Med"},{"issue":"24","key":"2021120906282167300_B58","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1056\/NEJMp0906516","article-title":"The breadth of hopes","volume":"361","author":"Feudtner","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120906282167300_B59","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/1049732312449210","article-title":"Divergent views of hope influencing communications between parents and hospital providers","volume":"22","author":"Roscigno","year":"2012","journal-title":"Qual Health Res"},{"issue":"7","key":"2021120906282167300_B60","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1001\/archpediatrics.2009.87","article-title":"Until the last breath: exploring the concept of hope for parents and health care professionals during a child\u2019s serious illness","volume":"163","author":"Reder","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"19","key":"2021120906282167300_B61","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/jama.284.19.2469","article-title":"Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care","volume":"284","author":"Wolfe","year":"2000","journal-title":"JAMA"},{"issue":"17","key":"2021120906282167300_B62","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1200\/JCO.2006.08.7759","article-title":"Understanding parents\u2019 approaches to care and treatment of children with cancer when standard therapy has failed","volume":"25","author":"Bluebond-Langner","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"2021120906282167300_B63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/1740774511414444","article-title":"Altruism among participants in cancer clinical trials","volume":"8","author":"Truong","year":"2011","journal-title":"Clin Trials"},{"key":"2021120906282167300_B64","volume-title":"Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries","author":"National Bioethics Advisory Commission","year":"2001"},{"issue":"5","key":"2021120906282167300_B65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15265160600862940","article-title":"Altruistic motives reconsidered","volume":"6","author":"Ladd","year":"2006","journal-title":"Am J Bioeth"},{"issue":"5","key":"2021120906282167300_B66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15265160600862478","article-title":"Improving medicine through research and the constitutive nature of altruism","volume":"6","author":"Hester","year":"2006","journal-title":"Am J Bioeth"},{"issue":"5","key":"2021120906282167300_B67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/15265160600862924","article-title":"Altruistic discourse and therapeutic misconception in research informed consent","volume":"6","author":"Joffe","year":"2006","journal-title":"Am J Bioeth"},{"issue":"35","key":"2021120906282167300_B68","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1200\/JCO.2012.42.3004","article-title":"Communicating and understanding the purpose of pediatric phase I cancer trials","volume":"30","author":"Cousino","year":"2012","journal-title":"J Clin Oncol"},{"issue":"4","key":"2021120906282167300_B69","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.291.4.470","article-title":"Communication of randomization in childhood leukemia trials","volume":"291","author":"Kodish","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"2021120906282167300_B70","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/1097-0142(20010801)92:3<691::AID-CNCR1372>3.0.CO;2-4","article-title":"Informed consent for pediatric leukemia research: clinician perspectives","volume":"92","author":"Simon","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"2021120906282167300_B71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1525\/jer.2008.3.3.57","article-title":"Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear?","volume":"3","author":"Kass","year":"2008","journal-title":"J Empir Res Hum Res Ethics"},{"key":"2021120906282167300_B72","first-page":"62","volume-title":"Quantity and Quality in Social Research","author":"Bryman","year":"1988","edition":"1st ed"},{"key":"2021120906282167300_B73","first-page":"25","volume-title":"Qualitative Methods for Health Research","author":"Green","year":"2014","edition":"3rd ed"},{"issue":"10","key":"2021120906282167300_B77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/adc.2009.180695","article-title":"Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia","volume":"95","author":"Chappuy","year":"2010","journal-title":"Arch Dis Child"},{"issue":"2","key":"2021120906282167300_B78","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/adc.2005.076141","article-title":"Parental consent in paediatric clinical research","volume":"91","author":"Chappuy","year":"2006","journal-title":"Arch Dis Child"},{"issue":"5","key":"2021120906282167300_B79","doi-asserted-by":"crossref","first-page":"e002733","DOI":"10.1136\/bmjopen-2013-002733","article-title":"Parental comprehension of the benefits\/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study","volume":"3","author":"Chappuy","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"2021120906282167300_B80","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00000542-200310000-00012","article-title":"Participation of children in clinical research: factors that influence a parent\u2019s decision to consent","volume":"99","author":"Tait","year":"2003","journal-title":"Anesthesiology"},{"key":"2021120906282167300_B81","doi-asserted-by":"crossref","first-page":"236S","DOI":"10.1016\/S0197-2456(01)00171-4","article-title":"Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial","volume":"22","author":"Janson","year":"2001","journal-title":"Control Clin Trials"},{"issue":"5","key":"2021120906282167300_B83","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM200002033420506","article-title":"Symptoms and suffering at the end of life in children with cancer","volume":"342","author":"Wolfe","year":"2000","journal-title":"N Engl J Med"},{"issue":"36","key":"2021120906282167300_B84","doi-asserted-by":"crossref","first-page":"9155","DOI":"10.1200\/JCO.2005.04.010","article-title":"Parent and physician perspectives on quality of care at the end of life in children with cancer","volume":"23","author":"Mack","year":"2005","journal-title":"J Clin Oncol"},{"issue":"12","key":"2021120906282167300_B82","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2467::AID-CNCR22>3.0.CO;2-M","article-title":"Informed consent in the Childrens Cancer Group: results of preliminary research","volume":"82","author":"Kodish","year":"1998","journal-title":"Cancer"},{"key":"2021120906282167300_B74","first-page":"48","volume-title":"Existential-Phenomenological Alternatives for Psychology","author":"Colaizzi","year":"1978"},{"issue":"35","key":"2021120906282167300_B75","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.1200\/JCO.2008.20.0204","article-title":"\u201cTrying to be a good parent\u201d as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children","volume":"27","author":"Hinds","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2021120906282167300_B76","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jpainsymman.2013.07.007","article-title":"Parents\u2019 experiences of pediatric palliative care and the impact on long-term parental grief","volume":"47","author":"van der Geest","year":"2014","journal-title":"J Pain Symptom Manage"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-003780\/1082591\/peds_2020003780.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-003780\/1082591\/peds_2020003780.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T09:37:31Z","timestamp":1697881051000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/3\/e2020003780\/33218\/End-of-Life-Childhood-Cancer-Research-A-Systematic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,1]]},"published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-003780","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"article-number":"e2020003780"}}